Day 12, Lecture 1: Clinical Correlation 3: Sickle Cell Flashcards
1
Q
Normal cells vs. Sickle Red cells
A
2
Q
Sickle Cell incidence in the USA
A
- 1 in 13 african americans carries the trait
- 1 in 365 African Americans has sickle cell disease
- Prevalence in US is approximately 100,000
3
Q
What causes Sickle cell
A
- Inherited disorder
- A missense mutation in the Beta subunit of (A to T) leads the substitution of a Valine for a glutamic acid. This causes polymerization
- The cells are normal in their oxygenated state but when the cells are deoxygenated they polymerize together
4
Q
What factors increase Polymerization of Sickle cells
A
- Increased Temperature
- Acidosis
- Dehydration
- Deoxygenation of RBC (i.e. distance from pulmonary bed)
- Absence of other normal hemoglobins (e.g. Hgb A, Hgb F)
5
Q
Sickle Cell Pathology
A
- Blockage of small capillaries by sickle cells
- Endothelial activation and damage
- Adherence of WBC to Endothelium
- Platelet and coagulation factor activation
6
Q
Sickle cell laboratory features
A
- Hemolytic Anemia
- low baseline hemoglobin (7-10g/dL)
- Elevated reticulocyte count
- Hyperbilirubinemia
- Increased Lactate Dehydrogenase
- Elevated WBC (decreased margination)
- Elevated platelets (decreased splenic function)
7
Q
Possible Sickle Cell Genotypes
A
- Hgb AS (sickle cell trait)
- Hgb SS (sickle cell disease-SS, Sickle cell anemia)
- Hgb SC (sickle cell disease-SC)
- Hgb Sbeta thalassemia
- Hgb S/other e.g. SE, SG, SO,SD
8
Q
Sickle Cell Pain
A
- Caused by ischemia or infarction of bone
- May occur at any site
- Often has a typical location
- may have swelling and warmth at site or have no physical findings other than pain
-
No lab test will tell if the pt is having pain
- Hgb, bilirubin, % of sickled cells on smear do not change from baseline values in most vaso-occlusive crises. Xray and MRI often not helpful
9
Q
Treatment of Vaso-occlusive Pain
A
-
Local heat
- (no ice packs)
- hydration
- combination of medications works better
- NSAIDS
- Opioids
- Non-pharm therapy
- Always consider other possible causes
- Conditions that anyone can have
- Appendicitis or gastroenteritis
- Sickle Cell Specific conditions
- Osteomyelitis or gallstones
- Conditions that anyone can have
10
Q
Strategies to Prevent Death form infection in sickle cell patients
A
11
Q
Acute chest sydrome Definition
A
- A new infiltrate on CXR accompanied by at least one of the following
- Chest pain
- Fever
- Hypoxia
- Respiratory Distress
- (SOB, Wheezing, cough)
- (note tha thsi is the second most common reason for sickel cell hospital admission)
12
Q
Risk factors for Stroke in Sickle Cell patients
A
- Prior symptoms (TIAs)
- Low steady state hemoglobin
- High WBC
- High blood pressure
- Recent Acute Chest Syndrome
- Abnormal Transcranial Doppler
13
Q
Treatment of Stroke in Sickle cell patients
A
- Acute
- Exchange transfusion to decrease Hgb S to <30%
- Rehabilitation if necessary
- Chronic
- Chronic Transfusion to prevent production of Sickle cells (keep Hgb S about 30%)- indefinite duration
- Decreases the incidence of 2nd storke form 50-90% to <10%
- Chelation therpay to prevent iron overload is necessary with the chronic transfusions
- Chronic Transfusion to prevent production of Sickle cells (keep Hgb S about 30%)- indefinite duration
- Prevention
- Transcranial Doppler screening
14
Q
Life expectancy in Sickle Cell disease
A
- Median Age of Survival (mid 1990s)
- Sickle cell disease-SS
- 40-45 years
- Sickle Cell-disease-SC
- 60-65 years
- Sickle cell disease-SS
15
Q
New Sickle Cell Disease Strategies
A
- Drugs to promote Hgb F
- e.g. Hydroxyurea
- Chemotherpay agent commonly used to treat chronic leukemia
- Dose limiting toxicity is myelosupression
- thus you must watch for dropping WBCs
- Azacitidine
- e.g. Hydroxyurea
- Stem Cell Transplant
- Gene Transfer Therapy
- gene addition
- Anti-sickling beta-globin vector
- Gamma-globin vector
- leads to reactivation of fetal hemoglobin
- gene addition